Mostrando entradas con la etiqueta Negocios. Mostrar todas las entradas
Mostrando entradas con la etiqueta Negocios. Mostrar todas las entradas

martes, 25 de febrero de 2014

Science of the Times: Widener experiments with ‘green chemistry'

In keeping with the running theme of environmentally aware columns recently, I spoke with Widener University’s chair of the Chemistry Department, Dr. Loyd Bastin, last week about that institution’s recent move to sign the Green Chemistry Commitment.

Widener now numbers among the 17 colleges and universities nationwide (as well as the first in Pennsylvania) to have signed the pledge, which basically recognizes the work that has already been taking place on the campus to bring the chemistry department in line with a sustainable and environmentally friendly curriculum.

For those who haven’t heard of it, “green” chemistry is more of a philosophy than anything else. Obviously, it is bound by the laws of physics that dictate how certain chemical compounds interact with one another, so it’s more a matter of choice in which of those compounds are used.

It does so with an eye to conservation, sustainability and safety by holding to a set of 12 principles laid out by Dr. John Warner, founder of Beyond Benign, the flagship nonprofit promoting these ideals.

The idea of “green chemistry” is not at all new. Bastin has been immersed in the stuff for 14 years and has been instrumental in developing its concepts at the college for half of that time.

What is somewhat new is that this philosophy is no longer on the fringes. Where Bastin used to go to conferences that first explained what green chemistry is before focusing on how to teach it, they now assume attendees know what they’re there for and simply go ahead with the latter part.

This environmentally conscious chemistry requires the use of less noxious substances, renewable stocks and even extends to reducing waste at the atomic level. The goal is to find ways of filling the needs of the various fields associated with chemistry in such a way that there are no remainders in the equation, so to speak.

I want sustainability really to be in everyone’s consciousness,” said Bastin. “I want everyone to think about the effect we’re having on the environment.

To that end, Bastin and colleagues like Dr. Krishna Bhat, assistant professor of chemistry, have been working to expand the scope of green chemistry at Widener. The seed he planted there in 2007 has since grown and spread not just within the chemistry and biology departments, but even into the business school, which now emphasizes environmentally sustainable business practices.

Even the president of the United States has gotten in on the action with the Environmental Protection Agency’s annual Presidential Green Chemistry Challenge.



The EPA has received nearly 1,500 nominations for 755 unique technologies between 1996 and 2012, according to its website, some of which have revolutionized the way chemistry impacts our daily lives.

Bastin pointed to one such innovation that found a more environmentally friendly way of producing ibuprofen, which has since become the industry standard.

And there are some surprising participants in these awards. Scattered among the various institutions of higher learning and think tanks one might expect are names like DOW Corning, Lockheed Martin and DuPont.

These might not typically be thought of as shining pillars of responsible chemical management, but that appears to be changing. The reason some of these companies are coming around to greener methods could be attributed to a conscious desire to have a less harmful impact on the planet, although the fact that less waste equals less chance to get sued probably plays a part, as well.

See, the problem with noxious byproducts is that you have to dispose of them properly or face the EPA firing squad. Neither option is necessarily cheap.

If, on the other hand, you can make essentially the same product with little or no waste, then you have a lot less to worry about in that regard. You can probably even charge a premium by slapping an “environmentally friendly!” sticker on it.

No one is going to fault you for wanting to make more money, not in this country. They will fault you, however, if you ruin the water table doing it.

And there is evidently a lot of money to be made. According to a 2011 report from Pike Research, green chemistry is expected to become a $100 billion industry within the next six years, more than half of which will be centered in the United States.

While there are currently no grant programs open solely to those who have signed onto the Green Chemistry Commitment, Bastin said Beyond Benign does envision a time when some professional development or research grants would only be available to signers.

For his part, Bastin will continue instilling these principles in the chemical engineers and business leaders of tomorrow. About one-quarter of incoming freshman will now have to take green chemistry classes as part of their respective majors next year, and even non major classes are getting in on the action.

The faster we can get these kids out into the real world with this idea of responsible, sustainable chemistry tucked squarely away inside their noggins, the sooner this will become the norm.

We might even one day achieve Warner’s dream that it will no longer be referred to as “green chemistry,” but simply “chemistry.

Alex Rose covers the Delaware County Courthouse for the Daily Times. Follow him on Twitter at @arosedelco. Check out his blog at delcoscience.blogspot.com. Email him at delcoscience@gmail.com. His column appears every Tuesday.

ORIGINAL: DelcoTimes
By Alex Rose, Delaware County Daily Times
02/24/14

lunes, 17 de junio de 2013

BIOLATAM: Punto de encuentro del negocio de la biotecnología Latino Americana

ORIGINAL: BioLatAm





Add caption


ENGLISH

BIOLATAM 2013 nace con el objetivo de posicionarse como evento líder en el área latinoamericana para fomentar el desarrollo de negocio entre empresas biotecnológicas, así como con los sectores usuarios (farmacéutico, productos sanitarios, alimentarias, veterinarias, energéticas, entre otros) de todo el mundo, con intereses particulares en el área latinoamericana.

BIOLATAM 2013 combinará conferencias, un partnering y eventos de networking, con el objetivo de facilitar las relaciones entre empresas internacionales, inversores, instituciones y centros de investigación del ámbito de la biotecnología y áreas relacionadas.

PROGRAMA
BIOLATAM 2013 contará con un programa que abordará, además de otros, los siguientes temas:

SESIÓN 1: Hacía una Bioeconomía sostenible para América Latina
  • La Estrategia de Bioeconomía de la Unión Europea: Oportunidades para América Latina
  • Tendencias en el mercado de Biocombustibles
  • Bioplásticos, un Mercado en crecimiento
SESIÓN 2: Medicina Personalizada basada en marcadores para luchar contra el Cáncer
  • Valoración de los resultados del estudio "Planning cancer control in Latin America and the Caribbean" publicado por Lancet Oncology
  • Estrategias de screening poblacional
  • Sistemas de diagnóstico y pronóstico temprano coste/efectivos
SESIÓN 3: Bioprospección y Biodiversidad
  • Situación regulatoria
  • Oportunidades en la prospección marina y terrestre
  • Casos de éxito en la gestión sostenible de la biodiversidad
SESIÓN 4. Terapias Avanzadas
  • El rol de los sistemas de donación y trasplantes ante el reto de la medicina regenerativa
  • Mapa de la excelencia científica en el área en Latinoamérica
  • Oportunidades en el ámbito de los proveedores privados de salud.
SESIÓN 5: Buenas prácticas en acceso al mercado en LATAM (patrocinio confirmado, no disponible)
  • El mosaico regulatorio en LATAM
  • El papel crítico de los distribuidores
  • Casos de éxito
SESIÓN 6: Biotecnología Alimentaria, la gran apuesta
  • Herramientas para el control de calidad y trazabilidad
  • Novedades en fermentaciones y probióticos
  • Ingredientes funcionales y nutrigenómica
SESIÓN 7: El impacto de la biotecnología en la Sanidad Animal y la Acuicultura
  • Nuevas vacunas
  • Sistemas de diagnóstico
  • Tecnología genómica aplicada al sector
  • Nuevas fuentes de alimentación
SESIÓN 8: Biotecnología para la Cosmética
  • Estrategias de búsqueda de nuevos extractos naturales
  • Tecnologías de ensayo in vitro
  • Soluciones nanotecnológicas
SESIÓN 9: Seminario de Capital Riesgo
Parte 1: Políticas públicas de apoyo al Capital Riesgo en biotecnología
Parte 2: Capital Riesgo en el ecosistema empresarial latinoamericano
  • Casos de éxito en fondos público privados
  • Oportunidades para participación cruzada entre Europa, EEUU y LATAM
  • Cómo acercar a las grandes fortunas y business angels al sector
SESIÓN 10: Biosimilares
  • Entorno regulatorio
  • Experiencias en fabricación
  • Situación y perspectivas en Latinoamérica
SESIÓN 11: Agrobiotecnología
  • Situación en Europa y EEUU
  • ¿Hay espacio para las PYMEs Biotech?
  • Investigación con especies de interés para Latinoamérica
SESIÓN 12: Políticas de cluster biotech en América Latina
  • El rol de las asociaciones empresariales
  • Bioparques y Bioincubadoras
  • Redes internacionales
SESIÓN 13: La Biotecnología como catalizador de la industria de Dispositivos Médicos
  • Innovación y emprendimiento en biomédica
  • Futuro de los dispositivos médicos basados en principios de biotecnología
  • Diagnóstico in vitro de enfermedades infecciosas
El programa de BIOLATAM 2013 está en desarrollo y se actualizará periódicamente:


viernes, 17 de mayo de 2013

Thermo Fisher to Buy Life Technologies for $13.6 Billion

ORIGINAL: Bloomberg
By Jeffrey McCracken & David Welch -
Apr 15, 2013

Thermo Fisher Scientific Inc., the second-biggest maker of life-sciences equipment by market value, agreed to buy Life Technologies Corp. for $13.6 billion in cash in a deal that expands its reach in medical testing.

The $76-a-share offer also includes the assumption of $2.2 billion in debt, Waltham, Massachusetts-based Thermo Fisher said in a statement today. With the debt, the deal is valued at about $15.8 billion. The per-share offer is 12 percent more than Life Technologies (LIFE)’ closing price of $68 on April 12.


Thermo Fisher Scientific Inc. agreed to buy Life Technologies Corp. for about $13.6 billion in an all-cash deal. Photographer: Michael Fein/Bloomberg
Life, based in Carlsbad, California, makes laboratory equipment that helps to map DNA, information used to diagnose disease, identify risks of certain conditions or better target medicines. The market for gene tests may expand to $25 billion from $5 billion within a decade as more doctors use a patient’s genetic makeup to tailor treatments, according to a report last year from UnitedHealth Group Inc. (UNH)

The purchase gives Thermo “reach across all the major technologies,” said Ross Muken, an analyst at International Strategy & Investment Group LLC in New York. “You now have a unique customer touch and a portfolio others will be unable to match.

While the price was “a little higher” than some investors had expected, “we still think ultimately people will view this as a positive,” he said in a telephone interview. 

Technology Deals Thermo Fisher declined 1.2 percent to $78.61 at the close in New York. Life Technologies gained 7.5 percent to $73.11.

Acquirers have announced or completed 1,941 deals for biotechnology or genetic technology companies over the past five years, with an average size of $145.2 million and a typical premium of 53 percent, according to data compiled by Bloomberg
. The largest deal was Roche Holding AG’s $44.05 billion purchase in 2009 of the portion of drugmaker Genentech Inc. it didn’t already own.

The potential of the gene-mapping technology drove Roche to make a $6.7 billion hostile takeover bid for Illumina Inc. (ILMN) last year, which was ultimately unsuccessful.

Sales for Life have increased by about 5 percent on average in each of the past three years, compared with a 20 percent gain at San Diego-based Illumina Inc., data compiled by Bloomberg show. Life reported revenue of $3.8 billion last year.

Life has been “a technology loser,” falling behind rivals in terms of DNA sequencing, said ISI’s Muken. Still, with private-equity and corporate bidders vying for the company, it was able to secure a “fair value, given its growth profile.

Life had been reviewing its options for at least three months and said in January that it was working with Deutsche Bank AG, as well as Moelis & Co., on the strategic review. Cravath, Swaine & Moore LLP acted as legal advisers.

JPMorgan Chase & Co. and Barclays Plc acted as financial advisers to Thermo Fisher, while Wachtell, Lipton, Rosen & Katz and WilmerHale LLP acted as legal advisers.

To contact the reporters on this story: Jeffrey McCracken in New York at jmccracken3@bloomberg.net; David Welch in New York at dwelch12@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net



viernes, 12 de noviembre de 2010

GE announces plans to purchase 25,000 EVs by 2015, will buy 12,000 GM vehicles

ORIGINAL: EGM Car Tech

En una medida orientada a consolidarse como un participante activo de la recuperación ambiental y a la vez como proveedor de la nueva energía, General Electric anuncia este compromiso para los próximos 5 años que dinamizará positivamente la industria de vehículos eléctricos. Y con seguridad le permitirá convertirse en un actor principal en el suminsitro de la infraestructura para energizar los vehículos eléctricos de toda clase.

2011 Chevrolet Volt
General Electric announced today that it will purchase 25,000 electric-vehicles by 2015 for its own fleet through its Capital Fleet Services business. GE said that it plans to convert half of its 30,000 global fleet and will partner with fleet customers to deploy a total of 25,000 electric-vehicles by 2015.

As a part of the plan, GE will purchase 12,000 General Motors vehicles, starting off with the Chevrolet Volt in 2011. Other vehicles will be added as manufacturers expand their EV portfolio.
“We make technology that touches every point of the electric vehicle infrastructure and are leading the transformation to a smarter electrical grid,” said GE Chairman and CEO Jeff Immelt. “This transformation will be good for our businesses and for our shareowners. Wide-scale adoption of electric vehicles will also drive clean energy innovation, strengthen energy security and deliver economic value.”

Refresher: The 2011 Chevrolet Volt is powered by 16-kWh, “T”-shaped lithium-ion battery that powers the electric drive unit, which allows it to drive 40 miles on battery power alone. The system puts out 149-hp and a maximum torque of 273 lb-ft, allowing the Volt to go from 0-60 mph in about 9 seconds, hitting a top speed of 100 mph. The battery can be re-charged by plugging into a household outlet and takes 4 hours to recharge on 240 volts, and about 10-12 hours on a standard 120-volt outlet. The Chevrolet Volt also carries an 84-hp 1.4 4-clyinder engine that allows the five-door, FWD sedan to travel additional miles while averaging a fuel-economy of 50 mpg. A fully charged battery and full tank of gas will allow the Volt to travel 310 miles. Prices for the 2011 Chevrolet Volt start at $41,000 but with a full federal income tax credit (which range from $0 to $7,500), the Volt can cost a total of $33,500.

2011 Chevrolet Volt:

   

Press Release:
GE Announces Largest Single Electric Vehicle Commitment, Commits To Convert Half Of Global Fleet By 2015
    GE to purchase 25,000 electric vehicles for its fleet and for fleet customers Wide-scale electric vehicle use expected to deliver  up to $500 million in near-term business for GE Announces new electric vehicle customer experience centers in Michigan, Minnesota
Fairfield, CT – November 11, 2010 GE (NYSE: GE) announced today it will purchase 25,000 electric vehicles by 2015 for its own fleet and through its Capital Fleet Services business – the largest-ever single electric vehicle commitment.

GE will convert at least half of its 30,000 global fleet and will partner with fleet customers to deploy a total of 25,000 electric vehicles by 2015.  GE will initially purchase 12,000 GM vehicles, beginning with the Chevrolet Volt in 2011, and will add other vehicles as manufacturers expand their electric vehicle portfolios.  GE and its partners will use a mix of electric vehicle technologies to meet their respective needs.  Chevrolet Volts will roll off production lines this month and other automakers are bringing electric vehicles to market. As this occurs, GE is in a strong position to help deploy the supporting infrastructure to help its 65,000 global fleet customers convert and manage their fleets.

GE owns one of the world’s largest fleets, operates a leading global fleet management business, and offers a portfolio of product solutions including charging stations, circuit protection equipment and transformers that touch every part of electric vehicle infrastructure development. This enables GE to lead wide-scale electric vehicle adoption and generate growth for its businesses.

“Electric vehicle technology is real and ready for deployment and we are embracing the transformation with partners like GM and our fleet customers,” said GE Chairman and CEO Jeff Immelt. “By electrifying our own fleet, we will accelerate the adoption curve, drive scale, and move electric vehicles from anticipation to action.

GE businesses including Capital Fleet Services, Energy and Licensing & Trading will benefit from an emerging electric vehicle market that could deliver up to $500 million  in GE revenue over the next three years. This includes rapidly developing markets for GE’s charging station, the WattStation.

GM CEO Dan Akerson said, “GE’s commitment reflects confidence that electric vehicles are a real-world technology that can reduce both emissions and our dependence on oil.  It is also a vote of confidence in the Chevrolet Volt, which we will begin delivering to retail customers by the end of this year.  We are pleased that the Volt will play a major role in this program, which will spur innovation and benefit our companies, our customers, and society as a whole.”

FedEx Chairman, President and CEO, and Electrification Coalition member Fred Smith said, “With more than 16.3 million vehicles in operation in 2009, the nation’s fleet can drive initial ramp-up scale in the battery industry and OEM supply chains. By buying these vehicles, GE is helping ramp up production which will help lower the price of vehicles and their components and make electric vehicles more visible and acceptable to the public at large. This is good for GE, good for our economy, and good for our nation.”

GE also announced today two electric vehicle customer experience and learning centers to provide customers, employees and researchers first-hand access to electric vehicles and developing technologies. One will be located outside of Detroit, in Van Buren Township, Michigan, as part of GE’s Advanced Manufacturing and Software Technology Center. The other will be located at GE Capital’s Fleet Services business headquarters in Eden Prairie, Minnesota, with several other centers to be announced in 2011. The centers will monitor and evaluate vehicle performance and charging behaviors, driver experiences, service requirements, and operational efficiencies, while also affording the opportunity to experience a variety of manufacturers and models, and gain insights on electric vehicle deployment.

GE is launching this comprehensive electric vehicle program as part of its ecomagination business strategy to accelerate the development and deployment of clean energy technology though innovation and R&D investment. In support of the announcement today, an electric vehicle readiness toolkit has been launched on ecomagination.com to help municipalities, customers, and individuals prepare for wide-scale electric vehicle deployment.
- By: Omar Rana